Brief Introduction of China Medical Device Industry Company

Established in 1966, China Medical Device Industry Corporation (CMIC) is a large state-owned enterprise directly under China Pharmaceutical Group Corporation (Sinopharm), which has long undertaken the planning and development of the national medical device field and foreign exchange, as well as the national disaster relief medical device reserve task, and is the president unit of China Medical Device Industry Association. Its main specific business includes domestic trade, import and export business, investment, R&D, manufacturing, exhibition and industry consulting services, with annual sales of nearly 500 million yuan. It is the largest medical device distribution enterprise in China at present, with strong economic strength and good government background.

China Medical Device Industry Company has a number of wholly-owned, joint venture, holding and shareholding enterprises. Related enterprises include: Sinopharm United Medical Devices Co., Ltd., Beijing Sinopharm Zhongkang Medical Devices Co., Ltd., Beijing Sinopharm Zhongbei Medical Devices Co., Ltd., Sinopharm Shanghai Medical Devices Co., Ltd., Guangdong Renbo Medical Devices Co., Ltd. and China Pharmaceutical Group Shenyang Shenzhong Medical Devices Co., Ltd., among which Sinopharm United Medical Devices Co., Ltd. is the first Sino-foreign joint venture medical device trading company approved by the Ministry of Commerce with a total investment of 20 million US dollars. Related production enterprises are: Shanghai Blood Science and Technology Industry Co., Ltd., Guangdong Dongjiang Electronic Instrument Factory and Kemeisi Medical Electronic Instrument Factory. In order to strengthen international cooperation, the company has set up wholly-owned companies in Europe and North America, and established joint ventures with well-known foreign companies such as Shimadzu Company and Doelger Company in China.

China Medical Device Industry Co., Ltd. is currently seeking strategic partners for shareholding system reform according to the requirements of the competent government departments. Chinese and foreign manufacturers, scientific research institutions, investors and all kinds of partners are welcome to discuss big plans and work together.